Literature DB >> 34796394

An unusual case of dysuria, pollakisuria, and eosinophilia: Answers.

Fabian Eibensteiner1, Ursula Tonnhofer2, Alexander Springer2, Hubert Kogler3, Leila Ronceray3, Azadeh Hojreh4, Christoph Aufricht1, Krisztina Rusai5.   

Abstract

Entities:  

Keywords:  Celiac disease; Cystic mass; Cystitis; Eosinophilia; Eosinophilic cystitis; Pediatric

Mesh:

Year:  2021        PMID: 34796394      PMCID: PMC8960575          DOI: 10.1007/s00467-021-05130-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


× No keyword cloud information.

Answers

What is the diagnosis and what is its most likely etiology? The patient has eosinophilic cystitis, which developed due to eosinophilia triggered by celiac disease. This is the first case in the current literature of a pediatric patient with celiac disease and concomitant symptomatic eosinophilic cystitis. Until now, only associations of celiac disease with peripheral blood eosinophilia and eosinophilic esophagitis in pediatric patients, as well as one association of an adult patient with eosinophilic cystitis, have been reported [1, 2]. The true etiology in many cases of eosinophilic cystitis remains elusive to this day, with several associations with hypereosinophilic syndromes, allergies, medications, and even with bladder trauma, especially in response to bladder catheterization [3, 4]. Under normal conditions, eosinophils are mainly found in the bone marrow, lymphoid organs, the mucosa of the gastrointestinal tract, and the uterus, but very rarely in other organ tissues. Secondary (reactive) eosinophilia is mainly driven by cytokines, whereas primary (clonal) forms of eosinophilia are mostly caused by tyrosine kinase gene fusions, involving the coding genes for platelet-derived growth factor receptor alpha (PDGFRA), beta (PDGFRB), or fibroblast growth factor receptor 1 (FGFR1). Secondary (reactive) eosinophilia has multiple causes, such as allergy, drugs, and parasitic disease, and respiratory, gastrointestinal, and rheumatologic disorders [1, 5, 6]. Overall, eosinophilic cystitis is a rare inflammatory disorder, especially in the pediatric population [3, 4]. It should be noted that the age of disease onset in the case presented here is very early (at 3 years of age) in contrast to currently published case reports, with a median age of disease onset of 6.5 years [3, 6–8]. What further examinations should be performed? Irrespective of its cause, prolonged or marked activation of eosinophils may lead to migration of eosinophils into other organ tissues, such as the heart, lung, skin, or urinary tract, resulting in tissue and subsequent end-organ damage. Therefore, evaluation for the presence of other end-organ damage is essential. Based on individual signs and symptoms, chest X-ray, electrocardiogram, echocardiography, abdominal ultrasound, tissue biopsies, and other evaluations should be performed [1, 5, 6]. We have investigated the peripheral blood for genetic mutations (PDGFRA, PDGFRB, FGFR1) for the most frequent primary (clonal) eosinophilic disease, which yielded negative results [1]. Thorough workup for other secondary end-organ damages did not reveal further involvement of other organs. In the absence of an underlying cause of eosinophilia, a bone marrow punction should be performed to rule out a hematological neoplasm. What is the treatment for this disease? The treatment of eosinophilic cystitis is unfortunately not well established — there have been no controlled studies performed to date. However, many cases in children are self-limiting [3]. First-line treatments typically involve the removal of the driving reason, followed by the use of antihistamines and corticosteroids. The use of transurethral indwelling catheters and surgical treatment have also been reported, although less frequently than in adults [1]. In the case of our patient, upon diagnosis of celiac disease, treatment with a gluten-free diet was initiated. This led to a significant decrease and then to normalization of peripheral eosinophila (3.7% of peripheral leukocytes and 0.3 × 109/L absolute eosinophil count) over the course of 3 months, and a decrease of bladder wall thickening to 0.6 cm after 6 months on a gluten-free diet. After 9 months of the gluten-free diet, initial symptoms for eosinophilic cystitis were completely relieved, and urinary bladder wall thickening remained at 0.6 cm.

Discussion

In the case presented here, eosinophilia may be caused by previously undetected celiac disease, leading to secondary (reactive) eosinophilia and subsequent symptomatic end-organ damage of the urinary bladder wall before distinct symptomatic presentation of the underlying gastrointestinal disorder. The percentage of peripheral eosinophilia in patients with celiac disease was reported in small case series only, with 4/10 and 3/7 patients with celiac disease, having peripheral eosinophilia, and eosinophilic esophagitis [9, 10]. An initial secondary (reactive) eosinophilia of 28% of peripheral leukocytes probably led to urinary bladder wall infiltration with inflammation causing bladder wall thickening up to 2 cm, which clinically correlated well with the boy’s symptoms at the time of diagnosis. This hypothesis is supported by only intermittent recovery upon symptomatic treatment with oxybutynin, and prolonged remission of symptoms, bladder wall formations, and peripheral blood eosinophilia after initiation of a gluten-free diet. Prognosis of eosinophilic cystitis is difficult to establish, due to very few pediatric cases worldwide. However, most cases are responsive to various treatments, while patients with prior allergic conditions and granulomatous diseases show high rates of recurrence [3]. Therefore, we currently keep this patient on close follow-up at 3-month intervals at our outpatient clinic.

Conclusions

In conclusion, we are the first to report the case of a 3-year-old boy with celiac disease causing symptomatic eosinophilic cystitis before the onset of gastrointestinal symptoms. Treatment of the underlying condition (celiacfig disease) has led to the resolution of eosinophilia and eosinophilic cystitis.
  10 in total

Review 1.  World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.

Authors:  William Shomali; Jason Gotlib
Journal:  Am J Hematol       Date:  2019-10       Impact factor: 10.047

Review 2.  The Association Between Celiac Disease and Eosinophilic Esophagitis: Mayo Experience and Meta-analysis of the Literature.

Authors:  Salim Hommeida; Mouaz Alsawas; Mohammad H Murad; David A Katzka; Rayna M Grothe; Imad Absah
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-07       Impact factor: 2.839

Review 3.  [Eosinophilic cystitis in children].

Authors:  J Cohen; B Letavernier; C Garel; J Boubnova; S Boudjemaa; A Bensman
Journal:  Arch Pediatr       Date:  2011-04-12       Impact factor: 1.180

4.  Guideline for the investigation and management of eosinophilia.

Authors:  Nauman M Butt; Jonathan Lambert; Sahra Ali; Philip A Beer; Nicholas C P Cross; Andrew Duncombe; Joanne Ewing; Claire N Harrison; Steven Knapper; Donal McLornan; Adam J Mead; Deepti Radia; Barbara J Bain
Journal:  Br J Haematol       Date:  2017-01-23       Impact factor: 6.998

5.  Case: Eosinophilic cystitis presenting as a bladder mass in an 11-year-old girl.

Authors:  Elsa Bey; Youssef Teklali; Pierre-Yves Rabattu; Simon Grandjean Lapierre; Christian Piolat
Journal:  Can Urol Assoc J       Date:  2017-11       Impact factor: 1.862

6.  Mass Forming Eosinophilic Cystitis in Pediatric Patients.

Authors:  Amy G Zhou; Ali Amin; Jennifer K Yates; David A Diamond; Monique M Tyminski; Joseph A Badway; Pamela I Ellsworth; Jeremy T Aidlen; Christopher L Owens
Journal:  Urology       Date:  2016-11-10       Impact factor: 2.649

Review 7.  Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases.

Authors:  D van den Ouden
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

8.  Eosinophilic esophagitis in children with celiac disease.

Authors:  Chee Y Ooi; Andrew S Day; Reuben Jackson; Tim D Bohane; Vivienne Tobias; Daniel A Lemberg
Journal:  J Gastroenterol Hepatol       Date:  2007-12-07       Impact factor: 4.029

Review 9.  Eosinophilic cystitis in the pediatric population: a case series and review of the literature.

Authors:  S Sparks; A Kaplan; M DeCambre; G Kaplan; N Holmes
Journal:  J Pediatr Urol       Date:  2013-02-04       Impact factor: 1.830

Review 10.  The spectrum of eosinophilic cystitis in males: case series and literature review.

Authors:  Oana-Eugenia Popescu; Steve K Landas; Gabriel P Haas
Journal:  Arch Pathol Lab Med       Date:  2009-02       Impact factor: 5.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.